SummitTX Capital’s Centessa Pharmaceuticals CNTA Stock Holding History

SummitTX Capital’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-206,847	Closed	-$8.22M	–	822
2026 Q1	$8.22M	Sell	206,847 -125,861	-38%	-$3.22M	0.26%	87
2025 Q4	$8.32M	Buy	+332,708	New	+$8.43M	0.25%	97
2025 Q2	–	Sell	-28,381	Closed	-$408K	–	791
2025 Q1	$408K	Buy	+28,381	New	+$464K	0.02%	593

SummitTX Capital's CNTA Position: Q2 2026 in Review

SummitTX Capital sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 206,847 shares — an estimated $8.22M sold.

SummitTX Capital first reported a position in CNTA in Q1 2025 and held it in 3 quarters. The position peaked at $8.32M in Q4 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

SummitTX Capital reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
SummitTX Capital sold 206,847 Centessa Pharmaceuticals shares in Q2 2026, an estimated $8.22M.
SummitTX Capital first reported a position in Centessa Pharmaceuticals in Q1 2025 and held it in 3 quarters.
SummitTX Capital's Centessa Pharmaceuticals position peaked at $8.32M in Q4 2025.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.